Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,783 | 82,221 | 63,469 | 46,618 | 31,749 |
| Receivables | 960 | N/A | 21,676 | N/A | N/A |
| Other current assets | 1,618 | 960 | 0 | 4,443 | 2,681 |
| TOTAL | $92,075 | $85,358 | $88,017 | $54,658 | $38,155 |
| Non-Current Assets | |||||
| PPE Net | 4,068 | 4,402 | 4,547 | 4,851 | 5,084 |
| Other Non-Current Assets | 6,153 | 6,079 | 5,554 | 5,695 | 5,904 |
| TOTAL | $10,220 | $10,481 | $10,101 | $10,546 | $10,988 |
| Total Assets | $102,295 | $95,839 | $98,118 | $65,204 | $49,143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 710 | N/A | 109 | 433 | 753 |
| Accounts payable and accrued liabilities | 7,381 | 11,081 | 12,698 | 9,961 | 11,091 |
| Accrued Expenses | 22,005 | 28,593 | 28,144 | 23,516 | 22,448 |
| Other current liabilities | 797 | 757 | N/A | N/A | N/A |
| TOTAL | $31,898 | $41,403 | $42,095 | $34,653 | $34,888 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,029 | 17,857 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 271 | N/A | N/A |
| Other Non-Current Liabilities | 7,093 | 7,354 | 7,609 | 7,860 | 8,097 |
| TOTAL | $25,122 | $25,210 | $7,609 | $7,860 | $8,097 |
| Total Liabilities | $57,020 | $66,614 | $49,704 | $42,512 | $42,985 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,160 | 2,798 | 2,721 | 2,414 | 2,414 |
| Common Shares | 10 | 8 | 8 | 7 | 7 |
| Retained earnings | -304,093 | -295,481 | -260,586 | -222,481 | -192,824 |
| TOTAL | $45,275 | $29,226 | $48,414 | $22,692 | $6,158 |
| Total Liabilities And Equity | $102,295 | $95,839 | $98,118 | $65,204 | $49,143 |